Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

RTTNews | 921 days ago
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.

EGFR inhibitors are critical therapeutic agents for the treatment of non-small cell lung cancer (NSCLC), pancreatic cancer, colorectal cancer, squamous-cell carcinoma of the head and neck, and breast cancer.

The company said this trial brings us one step closer to a new treatment option for underserved cancer patients as there is no specific treatment currently approved for the treatment of skin toxicities associated with EGFRi therapies.

The company added it will advance HT-001 into the clinical phase as it is a key treatment in the onco-dermatology space and anticipates beginning the Phase 2a trial in the first quarter of 2023.

read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews | 665 days ago
Swiss Market Slumps On Monday

Swiss Market Slumps On Monday

The Swiss stock market extended its losing streak to three sessions on Monday, shedding almost 40 points or 0.3 percent since the middle of last week.
RTTNews | 2h 6min ago
European Markets Close Mixed On Monday

European Markets Close Mixed On Monday

The major European markets closed mixed on Monday, mired in uncertainty over U.S. trade policies after the Trump administration indicated the deadline for imposing new tariffs on U.S. trade partners has been extended until August 1st.
RTTNews | 2h 16min ago
Tesla Shares Hit By Elon Musk's Plan To Form New Political Party

Tesla Shares Hit By Elon Musk's Plan To Form New Political Party

Tesla Inc. shares were losing around 8% in the morning trading on the Nasdaq on Monday after CEO Elon Musk announced his plans to launch a new U.S. political party following his ongoing feud with President Donald Trump over the 'One Big, Beautiful Bill.' Tesla founder and the former head of the Department of Government Efficiency or DOGE, launched the 'America Party' on Saturday in the latest...
RTTNews | 3h 47min ago
FTSE 100 Trades Below The Flatline

FTSE 100 Trades Below The Flatline

Persisting tensions on the trade front and growing concerns over U.K.'s fiscal outlook dampened sentiment and dragged down the FTSE 100 to negative territory.
RTTNews | 5h 50min ago
Domino's Pizza's Online $9.99 Offer Of Any Pizza With Any Toppings On July 7- Aug. 3

Domino's Pizza's Online $9.99 Offer Of Any Pizza With Any Toppings On July 7- Aug. 3

Domino's Pizza Inc., the largest pizza company in the world, announced its "Best Deal Ever' promotion, offering any pizza with any toppings for $9.99 each when they order online between July 7 and August 3. Domino's $9.99 deal includes Hand Tossed, Handmade Pan, New York Style, Gluten Free and Crunchy Thin Crust, as well as an assortment of sauces and toppings.
RTTNews | 5h 55min ago